- Investor's Business Daily•8 hours ago
Gilead will likely guide to declining 2017 sales, hamstrung on limited Hep C visibility, RBC said Wednesday.
- Motley Fool•12 hours ago
Gilead Sciences, Lantheus Holdings, and Mallinckrodt are three healthcare stocks in the bargain bin -- for now.
- Barrons.com•14 hours ago
Gilead Sciences (GILD) was one of my big losers last year--but I expect it to make a comeback at some point. It just might not be this quarter, when Gilead reports earnings on Feb. 7. RBC's Michael Yee ...
GILD : Summary for Gilead Sciences, Inc. - Yahoo Finance
Gilead Sciences Inc. (GILD)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Day's Range||71.50 - 72.47|
|52 Week Range||70.83 - 103.10|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||6.67|
|Dividend & Yield||1.88 (2.61%)|
|1y Target Est||N/A|